Pure Global

Respiratory Pathogen Detection Kit - India CDSCO Medical Device Registration

Respiratory Pathogen Detection Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000273_72bb11aad945d3bbc997d190a9f13930_eb7f9c618724d2cbd92b25c344919ea7. This device is marketed under the brand name RespiFinder® 2SMART. The license holder is ADT India Pvt. Ltd., and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
Respiratory Pathogen Detection Kit
UID: IMP/IVD/2022/000273_72bb11aad945d3bbc997d190a9f13930_eb7f9c618724d2cbd92b25c344919ea7

Brand Name

RespiFinder® 2SMART

License Holder

ADT India Pvt. Ltd.

Device Class

Class C

Approving Authority

CDSCO

Product Information

The RespiFinder® 2SMART (RespiFinder® 2SMART) Kit is a qualitative multiplex PCR test to detect and differentiate within 2.5 hours 16 RNA viruses, 2 DNA viruses as well as 4 bacteria, all of which can cause respiratory tract infections in humans: adenovirus, bocavirus, coronavirus NL63/HKU1, coronavirus OC43, coronavirus 229E, hMPV, influenza A, influenza B, influenza A H1N1pdm09, parainfluenza 1, parainfluenza 2, parainfluenza 3, parainfluenza 4, rhinovirus/enterovirus, RSV-A, RSV-B, Bordetella pertussis, Chlamydophila pneumoniae, Legionella pneumophila and Mycoplasma pneumoniae. The RespiFinder® 2SMART kit aids in the diagnosis of respiratory tract infection when used in conjunction with other clinical and laboratory findings. Negative results do not necessarily indicate absence of viral or bacterial respiratory tract infection; negative results should not be used as the sole basis for diagnosis, therapy, or other treatment decisions. Positive results do not exclude co-infection with other pathogens. The pathogen(RespiFinder® 2SMART) detected may not be the definite cause of disease. The RespiFinder® 2SMART is for use with LightCycler® 480 (RespiFinder® 2SMART) and Rotor-Gene Q (RespiFinder® 2SMART).

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing